scispace - formally typeset
H

Hanna Taipaleenmaki

Researcher at University of Hamburg

Publications -  16
Citations -  1252

Hanna Taipaleenmaki is an academic researcher from University of Hamburg. The author has contributed to research in topics: Wnt signaling pathway & Metastasis. The author has an hindex of 13, co-authored 16 publications receiving 1090 citations. Previous affiliations of Hanna Taipaleenmaki include University of Massachusetts Medical School.

Papers
More filters
Journal ArticleDOI

miR-218 Directs a Wnt Signaling Circuit to Promote Differentiation of Osteoblasts and Osteomimicry of Metastatic Cancer Cells

TL;DR: In this paper, the authors show that miR-218 is induced during osteoblast differentiation and has potent osteogenic properties, which can promote commitment and differentiation of bone marrow stromal cells by activating a positive Wnt signaling loop.

miR-218 Directs a Wnt Signaling Circuit to Promote Differentiation of Osteoblasts and Osteomimicry of

TL;DR: In metastatic breast cancer cells but not in normal mammary epithelial cells, miR-218 enhances Wnt activity and abnormal expression of osteoblastic genes (osteomimicry) that contribute to homing and growth of cells metastatic to bone.
Journal ArticleDOI

Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease

TL;DR: It is identified that aberrant expression of Runx2 in aggressive tumor cells is related to the loss of specific Runx 2-targeting miRNAs and that a clinically relevant replacement strategy by delivery of synthetic miRNas is a candidate for a therapeutic approach to prevent metastatic bone disease by this route.
Journal ArticleDOI

Estrogen Receptor α Mediates Proliferation of Osteoblastic Cells Stimulated by Estrogen and Mechanical Strain, but Their Acute Down-regulation of the Wnt Antagonist Sost is Mediated by Estrogen Receptor β

TL;DR: In this paper, the differential effects of ERα and -β in these processes in mouse long bone-derived osteoblastic cells and human Saos-2 cells were investigated, and it was shown that ERβ inhibition with 4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-β]pyrimidin-3-yl] phenol (PTHPP) increases basal proliferation similarly to strain or estradiol.